Anders RJ - Search Results

1

Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement.

Takaya N, Cai J, Ferguson MS, Yarnykh VL, Chu B, Saam T, Polissar NL, Sherwood J, Cury RC, Anders RJ, Broschat KO, Hinton D, Furie KL, Hatsukami TS, Yuan C. Takaya N, et al. Among authors: anders rj. J Magn Reson Imaging. 2006 Jul;24(1):203-10. doi: 10.1002/jmri.20599. J Magn Reson Imaging. 2006. PMID: 16739123

2

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm RH Jr, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group. Black HR, et al. Among authors: anders rj. J Hypertens. 2005 May;23(5):1099-106. doi: 10.1097/01.hjh.0000166853.26087.22. J Hypertens. 2005. PMID: 15834298 Clinical Trial.

3

Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes.

Serrano CV Jr, Nicolau JC, Venturinelli M, Baracioli LM, Anders RJ, Cannon CP, Ramires JA. Serrano CV Jr, et al. Among authors: anders rj. Cardiovasc Drugs Ther. 2003 Mar;17(2):129-32. doi: 10.1023/a:1025335718142. Cardiovasc Drugs Ther. 2003. PMID: 12975594 Clinical Trial.

4

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group. Black HR, et al. Among authors: anders rj. JAMA. 2003 Apr 23-30;289(16):2073-82. doi: 10.1001/jama.289.16.2073. JAMA. 2003. PMID: 12709465 Clinical Trial.

5

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.

White WB, Sica DA, Calhoun D, Mansoor GA, Anders RJ. White WB, et al. Among authors: anders rj. Am Heart J. 2002 Oct;144(4):657-65. doi: 10.1067/mhj.2002.124866. Am Heart J. 2002. PMID: 12360162 Clinical Trial.

6

A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.

Bakris G, Sica D, Ram V, Fagan T, Vaitkus PT, Anders RJ. Bakris G, et al. Among authors: anders rj. Am J Hypertens. 2002 Jan;15(1 Pt 1):53-7. doi: 10.1016/s0895-7061(01)02254-3. Am J Hypertens. 2002. PMID: 11824861 Clinical Trial.

7

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.

White WB, Johnson MF, Anders RJ, Elliott WJ, Black HR. White WB, et al. Among authors: anders rj. Am Heart J. 2001 Dec;142(6):1010-5. doi: 10.1067/mhj.2001.119127. Am Heart J. 2001. PMID: 11717605

8

Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist.

Nicholson NS, Abood NA, Panzer-Knodle SG, Frederick LG, Page JD, Salyers AK, Suleymanov OD, Szalony JA, Taite BB, Anders RJ. Nicholson NS, et al. Among authors: anders rj. Med Res Rev. 2001 May;21(3):211-26. doi: 10.1002/med.1007. Med Res Rev. 2001. PMID: 11301411

9

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD, Anders RJ. Black HR, et al. Among authors: anders rj. Hypertension. 2001 Jan;37(1):12-18. doi: 10.1161/01.hyp.37.1.12. Hypertension. 2001. PMID: 11208750

10

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.

Cannon CP, McCabe CH, Wilcox RG, Langer A, Caspi A, Berink P, Lopez-Sendon J, Toman J, Charlesworth A, Anders RJ, Alexander JC, Skene A, Braunwald E. Cannon CP, et al. Among authors: anders rj. Circulation. 2000 Jul 11;102(2):149-56. doi: 10.1161/01.cir.102.2.149. Circulation. 2000. PMID: 10889124 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters